May 14, 2020 / 12:53 PM / 16 days ago

BRIEF-Vaccinex Reports First Quarter 2020 Financial Results And Provides Corporate Update

Vaccinex Inc:

* VACCINEX REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* VACCINEX INC - CASH AND CASH EQUIVALENTS AND MARKETABLE SECURITIES ON MARCH 31, 2020 WERE $2.5 MILLION

* VACCINEX INC - ADVANCING PLANS TO EXPAND PEPINEMAB DEVELOPMENT TO INCLUDE ALZHEIMER’S DISEASE

* VACCINEX INC - APPROACHING KEY TOPLINE DATA IN NON-SMALL CELL LUNG CANCER AND HUNTINGTON’S DISEASE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below